Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20112381 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Monoclonal Antibody Treatment for Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: MRA 003 US

Study has passed its completion date and status has not been verified in more than two years.